Investigational Site 013 — Chicago, Illinois

Investigational Site 013 is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site 013 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Recurrent Pericarditis, Heart Diseases, Pericarditis.

Sponsors: Kiniksa Pharmaceuticals International, plc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site 013?

Investigational Site 013 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site 013 conducted?

Investigational Site 013 has 1 clinical trials on record, with 1 currently active. Their work covers Recurrent Pericarditis, Heart Diseases, Pericarditis.

Is Investigational Site 013 accredited by Crixeo Clinical Trials?

Investigational Site 013 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site 013?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.